Northwest Investment Counselors LLC Grows Stock Holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Northwest Investment Counselors LLC boosted its holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 5.8% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 14,294 shares of the medical instruments supplier’s stock after buying an additional 780 shares during the quarter. Northwest Investment Counselors LLC’s holdings in DENTSPLY SIRONA were worth $572,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Quadrant Capital Group LLC raised its position in shares of DENTSPLY SIRONA by 311.2% during the 4th quarter. Quadrant Capital Group LLC now owns 847 shares of the medical instruments supplier’s stock worth $27,000 after acquiring an additional 641 shares in the last quarter. BI Asset Management Fondsmaeglerselskab A S raised its holdings in DENTSPLY SIRONA by 123.2% during the first quarter. BI Asset Management Fondsmaeglerselskab A S now owns 1,078 shares of the medical instruments supplier’s stock worth $42,000 after purchasing an additional 595 shares in the last quarter. CI Investments Inc. lifted its position in shares of DENTSPLY SIRONA by 49.3% during the 4th quarter. CI Investments Inc. now owns 1,339 shares of the medical instruments supplier’s stock worth $43,000 after buying an additional 442 shares during the last quarter. Parkside Financial Bank & Trust boosted its holdings in shares of DENTSPLY SIRONA by 163.7% in the 1st quarter. Parkside Financial Bank & Trust now owns 915 shares of the medical instruments supplier’s stock valued at $46,000 after buying an additional 568 shares in the last quarter. Finally, Ellevest Inc. grew its position in shares of DENTSPLY SIRONA by 61.7% in the 1st quarter. Ellevest Inc. now owns 1,510 shares of the medical instruments supplier’s stock valued at $59,000 after buying an additional 576 shares during the last quarter. 95.70% of the stock is currently owned by institutional investors and hedge funds.

DENTSPLY SIRONA Stock Performance

Shares of NASDAQ XRAY traded down $0.05 during midday trading on Friday, reaching $35.54. 2,550,345 shares of the company were exchanged, compared to its average volume of 1,187,103. The stock has a market cap of $7.52 billion, a P/E ratio of -7.45, a PEG ratio of 2.03 and a beta of 0.97. DENTSPLY SIRONA Inc. has a 1 year low of $26.48 and a 1 year high of $43.24. The stock has a fifty day simple moving average of $38.64 and a 200 day simple moving average of $38.99. The company has a current ratio of 1.51, a quick ratio of 0.99 and a debt-to-equity ratio of 0.50.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its earnings results on Wednesday, August 2nd. The medical instruments supplier reported $0.51 earnings per share for the quarter, beating the consensus estimate of $0.43 by $0.08. DENTSPLY SIRONA had a positive return on equity of 10.29% and a negative net margin of 26.04%. The company had revenue of $1.03 billion for the quarter, compared to the consensus estimate of $998.98 million. The firm’s revenue for the quarter was up .5% compared to the same quarter last year. On average, research analysts forecast that DENTSPLY SIRONA Inc. will post 1.97 earnings per share for the current fiscal year.

DENTSPLY SIRONA Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, October 13th. Stockholders of record on Friday, September 29th will be paid a $0.14 dividend. This represents a $0.56 annualized dividend and a dividend yield of 1.58%. The ex-dividend date is Thursday, September 28th. DENTSPLY SIRONA’s dividend payout ratio (DPR) is presently -11.74%.

Analysts Set New Price Targets

XRAY has been the subject of several research analyst reports. StockNews.com assumed coverage on shares of DENTSPLY SIRONA in a research note on Thursday, August 17th. They issued a “buy” rating for the company. Barrington Research restated an “outperform” rating and set a $51.00 price target on shares of DENTSPLY SIRONA in a research note on Friday, August 4th. Three equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $42.13.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies for professional dental market worldwide. The company operates through two segments, Technologies & Equipment, and Consumables. The Technologies & Equipment segment provides dental equipment, such as treatment centers, imaging equipment, motorized dental handpieces, and other instruments for dental practitioners and specialists; dental CAD/CAM technologies for dental offices to support various digital dental procedures, including dental restorations; dentist-directed aligner solutions, SureSmile, and direct-to-consumer clear aligner solutions, as well as high frequency vibration technology device; implants; and urology catheters and other healthcare-related consumable products.